Ninety percent of people with cystic fibrosis benefit from lifesaving mutation-targeted therapies. Emily’s Entourage (EE) is leading the charge to close the gap for the final 10%. Over the past year, we’ve hit a turning point: therapies that EE helped to create and advance are progressing to clinical trials. This is our moment to transform hope into reality and achieve lifesaving breakthroughs for the final 10% of people with CF. Now is our time.



[addtoany]